Valuation: Adocia

Market Cap 70.63M 80.82M 66.39M 60.58M 114M 7.73B 114M 797M 307M 3.95B 304M 297M 12.72B P/E 2026 *
-659x
P/E 2027 * 5.22x
Enterprise Value 40.79M 46.67M 38.34M 34.98M 65.66M 4.46B 65.67M 460M 178M 2.28B 175M 171M 7.35B EV / Sales 2026 *
16.2x
EV / Sales 2027 * 2.85x
Free-Float
96.05%
Yield 2026 *
-
Yield 2027 * -
1 day+0.78%
1 week-1.47%
Current month-9.48%
1 month-13.43%
3 months-11.95%
6 months-33.15%
Current year-46.12%
1 week 3.52
Extreme 3.52
3.79
1 month 3.47
Extreme 3.474
4.17
Current year 3.47
Extreme 3.474
7.45
1 year 3.47
Extreme 3.474
12.4
3 years 2.86
Extreme 2.86
12.66
5 years 2.74
Extreme 2.745
16.16
10 years 2.74
Extreme 2.745
61.9
Manager TitleAgeSince
Chief Executive Officer 55 11/05/2023
Director of Finance/CFO - 23/09/2024
Chief Tech/Sci/R&D Officer - 01/12/2014
Director TitleAgeSince
Director/Board Member 55 19/04/2013
Chairman 57 -
Director/Board Member 61 11/05/2023
Date Insider Type Main position Quantity % Market Cap. Importance
27/02/25 Buy

Founder

109,170 0.6972%
06/04/24 Buy

Founder

15,576 0.1105%
06/04/24 Buy

Founder

51,921 0.3685%
Change 5-day change 1-year change 3-year change Capi.($)
+0.78%-1.47%-56.92%-54.25% 80.82M
-0.07%+7.14%+53.95%+111.00% 74.27B
-1.45%-0.40%+35.52%+79.18% 61.21B
-0.09%+5.33%+33.16%+20.37% 27.55B
-0.15%+0.75%-16.69%+361.67% 26.38B
+2.93%+4.32%+2.18%-3.60% 25.34B
+0.84%+6.00%+25.53%-9.89% 20.84B
-1.71%+4.60%-6.17%+518.09% 14.94B
+0.87%-3.73%+159.95%+327.53% 15.17B
+1.63%+2.20%+46.92%+170.72% 14.41B
Average +0.36%+2.06%+27.74%+152.08% 28.02B
Weighted average by Cap. +0.01%+2.96%+36.57%+135.84%

Financials

2026 *2027 *
Net sales 2.52M 2.89M 2.37M 2.16M 4.06M 276M 4.06M 28.44M 10.98M 141M 10.84M 10.6M 454M 35.4M 40.51M 33.27M 30.36M 56.98M 3.87B 56.99M 399M 154M 1.98B 152M 149M 6.38B
Net income -4.32M -4.94M -4.06M -3.7M -6.95M -472M -6.95M -48.7M -18.79M -241M -18.55M -18.15M -777M -44.33M -50.72M -41.66M -38.02M -71.35M -4.85B -71.37M -500M -193M -2.48B -190M -186M -7.98B
Net Debt -29.84M -34.15M -28.05M -25.6M -48.04M -3.26B -48.05M -337M -130M -1.67B -128M -125M -5.37B 30.18M 34.53M 28.36M 25.88M 48.58M 3.3B 48.58M 340M 131M 1.69B 130M 127M 5.43B
Logo Adocia
Adocia is a biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins for the treatment of diabetes. At the end of 2025, the group had a portfolio of 4 products in clinical development (BioChaperone Lispro U100 and U200, BioChaperone Combo, M1Pram and BioChaperone Glucagon) and 4 preclinical-stage products (AdoShell® Islets, AdOral® Sema, AdoGel® Sema and BioChaperone® CagriSema).
Employees
73
Date Price Change Volume
22/09/26 €3.610 +0.78% 62,153
21/09/26 €3.582 -1.86% 40,938
18/09/26 €3.650 -0.49% 42,096
17/09/26 €3.668 +1.78% 46,136
16/09/26 €3.604 -1.64% 67,707
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.610EUR
Average target price
9.700EUR
Spread / Average Target
+168.70%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ADOC Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!